Brokerages expect UnitedHealth Group Inc (NYSE:UNH) to report sales of $60.61 billion for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for UnitedHealth Group’s earnings, with the highest sales estimate coming in at $61.21 billion and the lowest estimate coming in at $59.92 billion. UnitedHealth Group reported sales of $56.09 billion in the same quarter last year, which suggests a positive year over year growth rate of 8.1%. The firm is scheduled to report its next quarterly earnings report on Tuesday, July 16th.
On average, analysts expect that UnitedHealth Group will report full-year sales of $243.86 billion for the current year, with estimates ranging from $241.80 billion to $244.97 billion. For the next fiscal year, analysts forecast that the business will post sales of $262.39 billion, with estimates ranging from $257.91 billion to $265.56 billion. Zacks’ sales averages are a mean average based on a survey of research firms that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $3.04 earnings per share.
Several analysts have issued reports on UNH shares. Credit Suisse Group restated a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research note on Friday, February 8th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. SunTrust Banks lowered their target price on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research note on Wednesday, April 17th. They noted that the move was a valuation call. Finally, Raymond James lowered their target price on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating on the stock in a research note on Wednesday, April 17th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $290.84.
In related news, CEO David S. Wichmann acquired 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 3rd. The shares were bought at an average cost of $231.79 per share, for a total transaction of $4,635,800.00. Following the purchase, the chief executive officer now owns 904,367 shares in the company, valued at approximately $209,623,226.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $239.02, for a total value of $1,195,100.00. Following the sale, the director now owns 77,993 shares in the company, valued at $18,641,886.86. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,930 shares of company stock worth $6,746,683. 0.87% of the stock is currently owned by corporate insiders.
Several large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. grew its position in UnitedHealth Group by 3.1% during the fourth quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after buying an additional 2,123,417 shares in the last quarter. Vanguard Group Inc grew its position in UnitedHealth Group by 1.6% during the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after buying an additional 1,073,505 shares in the last quarter. FMR LLC grew its position in UnitedHealth Group by 1.9% during the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after buying an additional 1,232,189 shares in the last quarter. Oregon Public Employees Retirement Fund grew its position in UnitedHealth Group by 50,446.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock worth $214,000 after buying an additional 53,244,249 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in UnitedHealth Group by 6.9% during the first quarter. Geode Capital Management LLC now owns 12,390,059 shares of the healthcare conglomerate’s stock worth $3,058,214,000 after buying an additional 796,658 shares in the last quarter. Institutional investors own 87.29% of the company’s stock.
Shares of UNH traded up $4.59 during mid-day trading on Thursday, hitting $241.38. The stock had a trading volume of 4,464,430 shares, compared to its average volume of 5,580,939. The firm has a market cap of $229.39 billion, a PE ratio of 17.80, a PEG ratio of 1.29 and a beta of 0.74. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group has a 52 week low of $208.07 and a 52 week high of $287.94.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Yield Curve
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.